Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment

Abstract Lymphoma is the most common hematological cancer in dogs. Canine diffuse large B cell lymphoma shows a relatively good response to treatment with multi-agent cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy; however, the 2-year survival rate is as low as 20%. F...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Takuya Mizuno, Yukinari Kato, Mika K. Kaneko, Yusuke Sakai, Toshinori Shiga, Masahiro Kato, Toshihiro Tsukui, Hirofumi Takemoto, Akio Tokimasa, Kenji Baba, Yuki Nemoto, Osamu Sakai, Masaya Igase
Format: article
Langue:EN
Publié: Nature Portfolio 2020
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/e1433744f59a4ad9a18dbad654843c03
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires